AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · Utah

HB0390

Veterans PTSD Clinical Research Amendments

Status

Enacted

2026 Session

IntroducedJan 27, 2026 (done)
PassedMar 11, 2026 (done)
SignedDate TBC (done)
Law in effectNext step (current)

Sponsor: Jennifer Dailey-Provost (Democrat)
Type: Clinical Research
Substances: Psilocybin

Official text

Summary (from PoliPsy)

Veterans PTSD Clinical Research Amendments

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: le.utah.gov

Legislative history

March 19, 2026
Passed
March 19, 2026
Passed
March 11, 2026
Enrolled (Passed Both Chambers)
February 25, 2026
Committee Report
February 20, 2026
Referred
February 18, 2026
Engrossed (Passed One Chamber)
February 10, 2026
Committee Report
February 5, 2026
Referred
January 27, 2026
Introduced

Loading bill…